Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
VANCOUVER, BC--(Marketwired - November 10, 2016) -According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research (www.idataresearch.com), the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies